Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Talazoparib by Pfizer for Bladder Cancer: Likelihood of Approval
Talazoparib is under clinical development by Pfizer and currently in Phase I for Bladder Cancer. According to GlobalData, Phase I...
Data Insights
Talazoparib by Pfizer for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
Talazoparib is under clinical development by Pfizer and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to GlobalData,...